Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
2000-03-07
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546146, A61K 3147, C07D21716
Patent
active
060340940
ABSTRACT:
The invention relates to the use of carbocyclically and heterocycally fused dihydroyridines as cerebroprotective agents, as agents for treating chronic inflammatory processes and as agents for inhabiting blood clotting, and also relates to new compounds of formula Ie ##STR1##
REFERENCES:
patent: 4322418 (1982-03-01), Losel et al.
Stroke A Journal of Cerebral Circulation, vol. 17, No. 4, Jul.-Aug. 1986--"The Effect of the Calcium Antagonist Nimodipine on the Gerbil Model of Experimental Cerebral Ischemia"--A. Fujisawa, et al., pp. 748-752.
Arndts Dietrich
Kuhn Franz Josef
Losel Walter
Roos Otto
Strelle Ilse
Boehringer Ingelheim KG
Dentz Bernard
Devlin M-E. M.
Raymond R. P.
Stempel A.
LandOfFree
Pharmaceutically useful 3,4-dihydroisoquinoline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically useful 3,4-dihydroisoquinoline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically useful 3,4-dihydroisoquinoline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363420